Filer Snapshot

Lyra Therapeutics, Inc.

CIK 0001327273. SEC filing timeline plus parsed ownership intelligence from 13F, 13D/G, and Forms 3/4/5 where available.

Entity type

Company

Total filings

375

Latest filing

20 Apr 2026

Industry

n/a

Filing-backed research brief

Start with the SEC data that changes for this CIK

Latest signal: SEC filing timeline only. Each card links back to the PortfolioSavvy page where the filing evidence is closest.

Go to filings Save page

Largest parsed holding

—

Populates from the latest parsed 13F information table.

Open holding

13D/G large stake

—

No recent parsed 13D/G stake row for this CIK.

Browse 13D/G

Save this filer page

Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.

Create free account and save this filer Already have an account? Sign in and save it
Source: SEC filing 25

25 filed on 20 Apr 2026 for CIK 0001327273.

View source filing
Listed symbols
LYRA on OTC
At a glance Names, identifiers, and filing context for this profile. 1 identity field
Business address
480 Arsenal Way, Watertown, MA, 02472
EDGAR profile Static EDGAR fields kept behind disclosure so the main profile stays readable. 3 profile fields available
Incorporated in
DE
Fiscal year end
31 December
Former names on EDGAR
480 Biomedical Inc. (to 28 Nov 2016) Arsenal Vascular Inc. (to 08 Nov 2011) Arsenal Medical Inc. (to 12 Aug 2010) WMR Biomedical Inc (to 27 Feb 2009)

Filer intelligence

What SEC filings say about Lyra Therapeutics, Inc.

A compact read of parsed XML filings. 13F, 13D/G, and Forms 3/4/5 are shown separately because they answer different ownership questions.

Save filer

SEC source mix

Counts show available parsed rows, not one combined ownership total.

No XML rows yet
13F portfolio No rows yet

Quarterly institutional portfolio holdings.

13D/G stakes No rows yet

Beneficial ownership and large-stake disclosures.

Forms 3/4/5 No rows yet

Officer, director, and 10% owner holdings or transactions.

No parsed ownership summary yet

We still show the SEC filing timeline below. The intelligence summary will populate when parsed 13F, 13D/G, or Forms 3/4/5 data exists for this CIK.

SEC filing record

CIK 0001327273 filing coverage

Start with this filing record, then use the linked ownership pages when parsed 13F, 13D/G, Forms 3/4/5, or facts data exists for this CIK.

SEC filings
375
First seen
09 May 2005
Latest filing
20 Apr 2026
Entity
Company

Observed form types

25 8-K 4 10-K EFFECT S-8 POS POS AM 144 SCHEDULE 13G SCHEDULE 13D/A +30 more

CIK-linked evidence first

Lyra Therapeutics, Inc. SEC filings Open SEC filing index

Latest Filings

Showing the latest 12 of 368 SEC filings for Lyra Therapeutics, Inc..

Open full filing history
25 File 001-39273

25

Filing date
20 Apr 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
03 Apr 2026
Reporting date
01 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
03 Apr 2026
Reporting date
01 Apr 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-278163

EFFECT filing

Filing date
26 Mar 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-264864

EFFECT filing

Filing date
26 Mar 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-272981

EFFECT filing

Filing date
26 Mar 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-237973

S-8 POS

Filing date
26 Mar 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-263402

S-8 POS

Filing date
26 Mar 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-270949

S-8 POS

Filing date
26 Mar 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .